Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
12 December, 2018 21:32 IST
Reliance arm acquires 16.31% stake in Genesis Colors
Source: IRIS | 10 Sep, 2018, 12.41PM
Comments  |  Post Comment

Reliance Industries announced that its subsidiary, Reliance (Q,N,C,F)* Retail Ventures (RRVL) has purchased 16.31% equity holding in Genesis Colors (GCL) for a consideration of Rs 348.0 million.

This is in addition to 49.46% equity holding in GCL held by Reliance Brands (RBL), a subsidiary of RRVL, intimation of which was given vide previous communication dated August 24, 2018. Accordingly, the aggregate equity shareholding of RRVL and RBL in GCL stands at 65.77%.

GCL's annual turnover in FY 2017-18 is Rs 860.2 million (provisional). GCL reported a turnover of Rs 800.4 million and Rs 1.14 billion in FY 2016-17 and FY 2015-16, respectively.

Shares of the company declined Rs 11.85, or 0.93%, to trade at Rs 1,264.90. The total volume of shares traded was 165,266 at the BSE (12.31 p.m., Monday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Ashok Leyland signs defence agreement with ELBIT Systems - 12-Dec-2018 09:41
Wipro launches automotive innovation center in Michigan - 12-Dec-2018 09:37
Liva Pharmaceuticals gets USFDA approval for its sANDA - Ranitidine Injection - 12-Dec-2018 09:35
Dr Reddy's Labs launches Omeprazole tablets in US market - 12-Dec-2018 09:31
Strides Vivimed JV receives consent for Albendazole tablets - 12-Dec-2018 09:27
Unichem Lab gets tentative nod for Tadalafil tablets - 12-Dec-2018 09:25
Zydus Wellness gets CCI approval for acquisition of Heinz India - 12-Dec-2018 09:20
Wipro Digital to expand Asia Pacific design capabilities in Australia - 11-Dec-2018 09:26
Wipro Digital to expand Asia Pacific design capabilities in Australia - 11-Dec-2018 09:24
Lupin receives tentative USFDA approval for Apixaban tablets - 11-Dec-2018 09:20
Lupin receives EIR from USFDA for Indore facility - 10-Dec-2018 16:10
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer